LONG-TERM SAFETY OF SODIUM OXYBATE IN PAEDIATRIC NARCOLEPSY WITH CATAPLEXY: OPEN-LABEL CONTINUATION AFTER 1 YEAR OF TREATMENT

被引：0
|
作者：
Strunc, M. J. [1 ]
Mignot, E. [2 ]
Wang, Y. G. [3 ]
Black, J. [2 ,3 ]
Chakravarthy, D. [3 ]
Parvataneni, R. [3 ]
Plazzi, G. [4 ]
机构：
[1] Childrens Hosp Kings Daughters, Ctr Pediat Sleep Med, Norfolk, VA USA
[2] Stanford Ctr Sleep Sci & Med, Stanford, CA USA
[3] Jazz Pharmaceut Inc, Palo Alto, CA USA
[4] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy
来源：
SLEEP MEDICINE | 2019年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S412 / S412
页数：1
相关论文
共 50 条
  • [41] Long-term disability improvement after alemtuzumab treatment is maintained in an open-label cohort
    Tuohy, O.
    May, K.
    Jones, J.
    Bjornson, I.
    Compston, A.
    Coles, A. J.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S443 - S443
  • [42] Long-Term Safety of Once-Nightly Sodium Oxybate for Narcolepsy: RESTORE Study Interim Analysis of Data
    Stern, Thomas
    Roy, Asim
    Shapiro, Colin M.
    Harsh, John
    Ajayi, Akinyemi O.
    Ibrahim, Sally
    Dubow, Jordan
    Gudeman, Jennifer
    ANNALS OF NEUROLOGY, 2023, 94 : S268 - S268
  • [43] LONG-TERM SAFETY OF ONCE-NIGHTLY SODIUM OXYBATE FOR NARCOLEPSY: RESTORE STUDY INTERIM ANALYSIS OF DATA
    Stern, T.
    Roy, A.
    Shapiro, C. M.
    Harsh, J.
    Ajayi, A. O.
    Ibrahim, S.
    Dubow, J.
    Gudeman, J.
    SLEEP MEDICINE, 2024, 115 : 220 - 221
  • [44] Efficacy and safety of long-term, open-label treatment with calcitriol in postmenopausal osteoporosis: A retrospective analysis
    Caniggia, A
    Nuti, R
    Martini, G
    Frediani, B
    Giovani, S
    Valenti, R
    Silvestri, G
    Matarazzo, M
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1996, 57 (11): : 857 - 868
  • [45] Cisapride in the long-term treatment of chronic gastroparesis: A 2-year open-label study
    Kendall, BJ
    Kendall, ET
    Soykan, I
    McCallum, RW
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1997, 25 (04) : 182 - 189
  • [46] Long-term efficacy and safety of adalimumab in the treatment of active ankylosing spondylitis: Results of an open-label, 2-year trial
    Haibel, H.
    Brandt, H. C.
    Baraliakos, X.
    Rudwaleit, M.
    Listing, J.
    Braun, J.
    Kupper, H.
    Sieper, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 218 - 219
  • [47] EFFICACY AND SAFETY OF LONG-TERM TREATMENT WITH LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: RESULTS OF A 2-YEAR, OPEN-LABEL EXTENSION STUDY
    Correll, C.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Loebel, A.
    Coghill, D.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2019, 53 : 105 - 105
  • [48] Long-Term Safety, Tolerability, and Durability of Treatment Effect of Olanzapine and Samidorphan: Results of a 4-Year Open-Label Study
    Ballon, Jacob S.
    Kahn, Rene S.
    Arevalo, Christina
    Dunbar, Martin
    Mcdonnell, David
    Correll, Christoph U.
    JOURNAL OF CLINICAL PSYCHIATRY, 2025, 86 (01)
  • [49] Chronic administration of sodium oxybate produces significant and long-term improvements in narcolepsy symptoms
    Hagaman, MH
    SLEEP, 2001, 24 : A327 - A328
  • [50] Long-term open-label treatment with Sativex® in patients with multiple sclerosis
    Constantinescu, C. S.
    Sarantis, N.
    MULTIPLE SCLEROSIS, 2006, 12 : S111 - S111
12345